Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery
Reduction of Acute Renal Failure Associated With Cardiovascular Surgery: A Randomized Study Comparing Sodium Bicarbonate to Normal Saline
Sponsor: Wake Forest University Health Sciences
A PHASE2 clinical study on Kidney Failure, Acute and Renal Replacement Therapy, this trial is completed. The trial is conducted by Wake Forest University Health Sciences and has accumulated 9 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Nov 2018 — Jan 2021 [monthly]
Completed PHASE2
Phase: NA → PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Completed NA
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Dec 2017 [monthly]
Completed NA
First recorded
May 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .